NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals)

Our Process Intensification (PI) Program, established in 2020, was the first NIIMBL-Led Program, and has been led by Dr. John Erickson since its inception. Over the past six years, the program has grown to include most of our large industry member companies and more than 400 world class subject matter experts have contributed to it. In the past...

Manufacturing USA continues to pursue its mission of strengthening U.S. global leadership in advanced manufacturing by connecting people, ideas, and technology to solve industry-relevant challenges. The network’s institutes serve as hubs for key technology areas including automation, biomanufacturing, and cybersecurity, ensuring that what is...

NIIMBL’s Viral Vector Program has awarded funding to Michigan Technological University to evaluate methods for detecting adeno-associated virus (AAV) aggregation in gene therapy manufacturing. The project will help the biopharmaceutical industry identify a reliable analytical method to support safe, cost-effective gene therapy production.

The...